We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Neovacs to Expand Clinical Testing of its TNF-a Kinoid Lead Product Candidate
News

Neovacs to Expand Clinical Testing of its TNF-a Kinoid Lead Product Candidate

Neovacs to Expand Clinical Testing of its TNF-a Kinoid Lead Product Candidate
News

Neovacs to Expand Clinical Testing of its TNF-a Kinoid Lead Product Candidate

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Neovacs to Expand Clinical Testing of its TNF-a Kinoid Lead Product Candidate"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Neovacs has announced that subject to regulatory consent, it plans to initiate a Phase II study of its TNF-a Kinoid later this year in rheumatoid arthritis patients who have failed treatment with at least one TNF-a inhibitor.

The decision to proceed with the trial was based on an initial review of encouraging data from the company’s Phase I/II study in Crohn’s disease.
Advertisement